TGFB1 and cancer: While neither effect was significant due to high variation between different donors a significant increase in the secretion of TGFβ was observed with H1 in T cell stimulated and anti-PD-1 treated explants (Figure 7J) supporting its role as a factor promoting immunosuppression and resistance in cancer.